Originally published In Press as doi:10.1074/jbc.M110407200 on February 19, 2002
J. Biol. Chem., Vol. 277, Issue 19, 17327-17333, May 10, 2002
Cross-talk in the A1-ATPase from Methanosarcina
mazei Gö1 Due to Nucleotide Binding*
Ünal
Coskun
,
Gerhard
Grüber
§,
Michel H. J.
Koch¶,
Jasminka
Godovac-Zimmermann
,
Thorsten
Lemker**, and
Volker
Müller**
From the
Universität des Saarlandes,
Fachrichtung 2.5-Biophysik, D-66421 Homburg, ¶ European Molecular
Biology Laboratory, Hamburg-Outstation, EMBL c/o DESY,
D-22603 Hamburg, Germany,
University College London,
Centre for Molecular Medicine, London WC1E 6JJ, United Kingdom, and
** Lehrstuhl für Mikrobiologie der
Ludwig-Maximilians-Universität München,
D-80638 München, Germany
Received for publication, October 30, 2001, and in revised form, February 18, 2002
 |
ABSTRACT |
Changes in the
A3B3CDF-complex of the
Methanosarcina mazei Gö1 A1-ATPase in
response to ligand binding have been studied by small-angle x-ray
scattering, protease digestion, fluorescence spectroscopy,
matrix-assisted laser desorption ionization time-of-flight mass
spectrometry, and CuCl2-induced disulfide formation. The value of the radius of gyration, Rg, increases
slightly when MgATP, MgADP, or MgADP + Pi (but not
MgAMP-PNP) is present. The nucleotide-binding subunits A and B were
reacted with
N-4[4-[7-(dimethylamino)-4-methyl]coumarin-3-yl]maleimide, and spectral shifts and changes in fluorescence intensity were detected
upon addition of MgAMP-PNP, MgATP, MgADP + Pi, or MgADP. Trypsin treatment of A1 resulted in cleavage of the stalk
subunits C and F, which was rapid in the presence of MgAMP-PNP
but slow when MgATP or MgADP were added to the enzyme. When
A1 was supplemented with CuCl2 a clear
nucleotide dependence of an A-A-D cross-linking product was generated
in the presence of MgADP and MgATP but not when MgAMP-PNP or MgADP + Pi was added. The site of cross-link formation was located
in the region of the N and C termini of subunit D. The data suggest
that the stalk subunits C, D, and F in A1 undergo
conformational changes during ATP hydrolysis.
 |
INTRODUCTION |
The membrane-integrated archaeal
A1AO-ATPase
(A3B3CDEFGHIKx, the exact stoichiometry
of the subunits is unknown), like the bacterial
F1FO-ATPase
(
3
3

abcx) and the eucaryotic V1VO-ATPase
(A3B3CDEFGxHyaczde), possesses an extrinsic domain (A1), containing the
catalytic sites, and an intrinsic domain (AO), involved in
ion translocation (1-3). The primary structure of the archaeal ATPase
is very similar to that of the V-ATPase, but its function, as an
ATP-synthase, is more similar to that of F-ATPases (2, 4-6). Electron
microscopy has shown that the major nucleotide-binding subunits A and B
of the A1/V1 and the corresponding
and
subunits of the F1 form an alternating hexagonal
arrangement (7-9) around a central mass (10, 11). The hexameric
headpiece is attached to the
AO/FO/VO part by at least one stalk
(3). Recent three-dimensional structures of F1 (12) and
V1 (13) confirm these features and show the stalk part
extending from and therefore partly composed of F1 (
-
; mitochondrial subunit nomenclature (12)) and V1
subunits (C-H).
The A3B3CDF complex of the Methanosarcina
mazei Gö1 A1-ATPase, which is investigated here,
consists of an ~96-Å long headpiece and an 84-Å high and 60-Å
diameter stalk as shown by small-angle x-ray scattering (14). A
comparison of the central stalk of this A1 complex with the
F1- and V1-ATPase indicates different shapes
and lengths of these domains (3, 14) which account for linking
catalytic events in the headpiece with ion pumping through the membrane
portion. In particular, the F1-ATPase has a significantly
shorter stalk than A1, ~40-45 Å long and 50-53 Å wide
(12, 15). The prevailing view is, however, that ATP hydrolysis in the
A1 headpiece is coupled to ion flow in AO
through movements of the central stalk subunit(s) (2) as visualized by
optical microscopy for F1 by fixing this enzyme on a
surface and attaching either an actin filament or a bead to the
subunit to mark its orientation (reviewed in Ref. 16). Although the energy-transducing mechanism of A-ATPase is thought to be similar to
that of the F-ATPase, evidence for structural alterations during coupling in the A-ATPase has been lacking. Here we describe this phenomenon in the A1-ATPase by a variety of biophysical and
biochemical methods. Altered overall dimensions of the A1
complex, fluorescence changes, trypsin susceptibility, and
CuCl2-induced cross-link formation between various subunits
of A1 are discussed in the light of different
ligand-dependent states.
 |
EXPERIMENTAL PROCEDURES |
Materials--
All chemicals were at least of analytical grade
and were obtained from Biomol (Hamburg, Germany), Merck, Promega
(Madison, WI), Sigma, or Serva (Heidelberg, Germany).
Purification of A1-ATPase--
The
A1-ATPase from M. mazei Gö1 was obtained
from Escherichia coli strain DK8 expressing the
A1-ATPase genes A-G on a multicopy vector pTL2 (17). The
enzyme was isolated by gel permeation chromatography followed by ion
exchange chromatography, as will be described
elsewhere.1 For solution
x-ray scattering experiments (see below) the enzyme was subsequently
applied onto a Sephacryl S-300 HR column (10/30, Amersham Biosciences)
equilibrated in 50 mM Tris-HCl (pH 6.9), 150 mM
NaCl and subjected to gel permeation chromatography
(FPLC)2 in order to isolate a
homogeneous and nucleotide-depleted A1 complex (14). The
purity and homogeneity of the protein sample was analyzed by
Native-PAGE (18) and SDS-PAGE (19). SDS gels were stained with
Coomassie Brilliant Blue G-250. Protein concentrations were determined
according to Lowry et al. (20). ATPase activity was measured
as described previously (14, 21).
CuCl2-induced Cross-link Formation--
Bound
nucleotides were removed by passing the A1 complex through
a size exclusion column (Superdex 200 HR (10/30), Amersham Biosciences)
equilibrated in 20 mM Tris-HCl (pH 7.4) and 150 mM NaCl. After preincubation of the enzyme with 5 mM nucleotide for 5 min, cross-linking was induced by
supplementation with 2 mM CuCl2 in a buffer
containing 20 mM Tris-HCl (pH 7.4) and 150 mM NaCl on a rotary shaker (450 rpm) at 4 °C for 30 min. The
cross-linking reaction was stopped by addition of 10 mM
EDTA, subsequently dissolved in DTT-free dissociation buffer, and
applied to an SDS-polyacrylamide gel as described above. The subunits
involved in cross-linking were identified by Western blotting (22)
using antisera against subunit A and B as described previously (17) and
mass spectrometric analysis. For the latter the cross-linked bands were
cut out from the SDS-polyacrylamide gel and destained with a solution
of 25 mM ammonium bicarbonate and 50% acetonitrile for
12 h. The gel band was cut into pieces of 1 mm3, which
were washed three times with acetonitrile, dried for 30 min in a
speed-vacuum concentrator, and digested according to a procedure
modified from Hellmann et al. (23) and Roos et
al. (24). For MALDI mass spectrometry, aliquots of 0.5 µl of the digested solution were applied to a target disc and allowed to dry in
the air. Subsequently, 0.5 µl of matrix solution (1% w/v
-cyano-4-hydroxycinnamic acid in 50% acetonitrile, 0.1% (v/v) trifluoroacetic acid) was applied to the dried sample and also allowed
to dry. Spectra were obtained using a Bruker Biflex III MALDI-TOF mass
spectrometer. The protein fragments were identified using programs from
the University of California, San Francisco (rafael.ucsf.edu/cgi-bin/msfit), the ProFound program of Rockefeller University (prowl.rockefeller.edu/cgi-bin/ProFound), the
PepSearch program of the EMBL in Heidelberg
(www.mann.embl-heidelberg.de/Services/PeptideSearch/FR_peptideSearchForm.html), and TagIdent available on the ExPASy WWW server.
Labeling A1-ATPase by CM2 and
Fluorescence Measurements--
Before labeling with
N-[4-[7-(dimethylamino)-4-methyl]coumarin-3-yl)]maleimide
(CM), A1 was depleted of nucleotides as described above.
The enzyme was labeled with 50 µM CM for 10 min in 20 mM Tris-HCl (pH 6.9) and 150 mM NaCl (buffer
A). Excess label was removed by one pass through a Sephadex G-25 spin
column, equilibrated in buffer A. Fluorescence emission spectra of
CM-bound A1 in the presence and absence of 5 mM
of different nucleotides were recorded at 10 °C using an SLM-Aminco
8100 spectrofluorimeter. Protein samples were excited at 365 nm, and
the emission was recorded from 410 to 560 nm with excitation and
emission bandpasses set to 4 nm. In order to determine the amount of
hydrolyzed MgATP after the fluorescent measurement, a 200-µl portion
of the sample was denatured with 20 µl of 14% perchloric acid and
cooled on ice for 15 min. The denatured protein was then pelleted by
centrifugation at 5000 rpm for 2 min (25, 26). The supernatant was
transferred to a microcentrifuge tube containing 3 µl of 5 M K2CO3 for neutralization. The
nucleotide content of 100-µl samples of this supernatant was determined by FPLC (Econo-System, Bio-Rad) using a DEAE-MEMSEP (10/10)
column eluted by a linear gradient of 0-1 M triethylamine, pH 7.5, at a flow rate of 5 ml/min at room temperature. The eluents were monitored by absorption at 254 nm, and the amounts were determined by integration of absorption peaks, calibrated with ATP and ADP standards.
Trypsin Digestion Studies--
A1-ATPase was
incubated at a concentration of 8 µg with trypsin in a ratio of 900:1
(w/w) in 20 mM Tris-HCl (pH 7.5) and 150 mM
NaCl in the absence or presence of 5 mM nucleotide at
30 °C. Trypsin cleavage was stopped by addition of the protease
inhibitor Pefabloc SC (8 mM). Peptides were separated by
SDS-PAGE (14).
X-ray Scattering Experiments and Data Analysis--
The
synchrotron radiation x-ray scattering data were collected following
standard procedures on the X33 camera (27-29) of the EMBL on the
storage ring DORIS III of the Deutsches Elektronen Synchrotron (DESY)
using multiwire proportional chambers with delay line readout (30).
Solutions with protein concentrations of 4.3 and 7.9 mg/ml were
measured. At sample detector distances of 3.9 m and 1.4 m and
a wavelength
= 0.15 nm, the ranges of momentum transfer
0.14 < s < 2.1 nm
1 were covered
(s = 4
sin
/
, where 2
is the scattering
angle). The data were normalized to the intensity of the incident beam and corrected for the detector response; the scattering of the buffer
was subtracted, and the difference curves were scaled for concentration
using the program SAPOKO.3
The maximum dimension, Dmax, of the
A1-ATPase samples, their distance distribution function
p(r) and radii of gyration,
Rg, were computed by the indirect Fourier transform
program GNOM (31, 32). The molecular masses of the solutes were
estimated by comparison with the forward scattering of a reference
solution of bovine serum albumin.
 |
RESULTS |
Effect of Substrate Binding Studied by X-ray Solution
Scattering--
Previously, we have characterized the
A1-ATPase from M. mazei Gö1 by small-angle
x-ray scattering (SAXS) and determined the maximum dimension (18.0 ± 0.1 nm) and the radius of gyration (Rg, 5.03 ± 0.1 nm (14)). Here SAXS was used to investigate possible changes of
the quaternary structure of A1 due to substrate binding. Fig. 1 displays a native gel and the
scattering profile of A1, free of loosely bound nucleotides
and an ATPase activity of ~8.0 µmol of ATP hydrolysis per mg of
enzyme per min. The radius of gyration (5.02 ± 0.1 nm) is in
agreement with previous results (14). However, when 5 mM
MgADP, MgADP + Pi, or MgATP was added to the protein
solution, the radii of gyration of the complexes increased to 5.14 ± 0.1, 5.21 ± 0.1, and 5.23 ± 0.1 nm, respectively (see
Table I). In the presence of the
unhydrolyzable ATP analogue, AMP-PNP, the enzyme had a slightly lower
Rg = 4.92 ± 0.1 nm. The maximum dimension of
the unligated or ligated A1-ATPase remained the same
(18.0 ± 0.1 nm).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Native-PAGE and experimental scattering
curves of the A3B3CDF-complex of the
A1-ATPase. A, the homogeneity and purity of
the A1-complex has been proven by Native-PAGE (lane
1) before exposure to x-rays using a gradient of 4-15%.
Lane 2, the V1-ATPase and the
V1( C) complex from M. sexta with apparent
molecular masses of 600 and 560 kDa (13), respectively, were used as
molecular mass standard. B, x-ray small-angle scattering
curves of the A1 complex before (curve 1) and
after the addition of 5 mM MgAMP-PNP (curve 5),
MgATP (curve 4), MgADP+Pi (curve 3),
and MgADP (curve 2), collected at 10 °C. The curves are
displaced by 1 logarithmic unit for better visualization.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Experimentally determined radii of gyration, Rg, of
the A1-ATPase from M. mazei Gö1 dependent on
nucleotide conditions
|
|
CM Labeling of A1 and Spectroscopic
Investigations--
To characterize further the structural changes
described above, the nucleotide-binding subunits A and B were
specifically labeled using the fluorescent label CM, as visualized on
the polyacrylamide gel in Fig.
2A. The higher intensity of CM
bound at subunit A may be due to the fact that subunit A includes five
Cys residues (Cys28, Cys65,
Cys173, Cys255, and Cys372 (33))
and thereby more possible sulfhydryl groups reacting with the
maleimide. The activity of the CM-bound enzyme was not altered by the
chemical modification. Fig. 3 shows the
fluorescence spectrum of the CM labeled A1-ATPase, which
was freed of bound nucleotides (Fig. 3, curve
) as
described under "Experimental Procedures." For comparison, addition
of 5 mM MgATP to the protein (in a 1:1 ratio) causes the
signal to increase and to shift to shorter wavelength (Fig. 3,
curve
). Addition of MgADP (Fig. 3, curve
)
gave a spectrum similar to that obtained with MgATP but with a lower
fluorescence maximum. In contrast, A1-ATPase in the
presence of MgADP + Pi (Fig. 3, curve
)
displayed a lower fluorescence intensity and a small blue shift.
Interestingly, addition of the non-cleavable nucleotide analogue
AMP-PNP (Fig. 3, curve
) caused an increase of the
fluorescence signal, indicating that the MgATP-bound enzyme is
catalyzing ATP hydrolysis during the measurements. This is also
confirmed by the fact that 85% of the added MgATP is still present
after the fluorescence measurement, as determined by FPLC. The results
presented indicate that the fluorescence spectrum of CM bound to
subunits A and B is sensitive to nucleotide binding.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 2.
Labeling of subunits A and B by
CM. The enzyme was reacted with CM as described under
"Experimental Procedures" and applied to a 17.5% total acrylamide
and 0.4% cross-linked SDS-polyacrylamide gel. A, the gel
stained with Coomassie Blue G-250; B, the fluorogram of the
same gel.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 3.
Nucleotide-induced fluorescence changes of
the CM-bound A1-ATPase. The fluorescence emission
spectra of the A1-ATPase was measured with a protein
concentration of 200 nM and a 1:1 ratio of Mg2+
to nucleotide at 10 °C. The enzyme was diluted in 20 mM
Tris-HCl (pH 6.9) and 150 mM NaCl and preincubated with 5 mM MgAMP-PNP (curve ), MgATP
(curve ), MgADP (curve ), and MgADP + Pi (curve ) on ice. Curve ,
A1-ATPase in the absence of nucleotides. The spectra were
recorded at ex of 365.1 nm over a range of 410-560 nm
with the emission and excitation slits at 4 nm.
|
|
Cross-linking of A1 Subunits Induced by
CuCl2--
Intersubunit cross-linking is a useful method
for establishing the relative position of subunits (34-36). Disulfide
bond formation was mediated by Cu2+. Fig.
4A illustrates the results of
cross-linking of the A1-ATPase with CuCl2 under
different nucleotide conditions. When the enzyme was incubated with 5 mM MgAMP-PNP at 4 °C before Cu2+ treatment,
two new bands (I and V) involving subunit(s) B (I) and A-B (V) were
generated, as indicated by Western blotting with antibodies to subunits
A and B (Fig. 4B). MALDI mass spectrometry confirmed that
band I derived from subunit B by identifying the peptides
Ala102-Arg120,
Gly271-Arg286, and
Ala366-Arg379. When A1 was
suspended in MgADP + Pi, the cross-link product I and a low
amount of band V are obtained. In the presence of MgATP the bands I and
V increased, and the new bands III, IV, and VI-VIII appeared, including
the subunits A-A (III) and A-A-D (IV), respectively, and several forms
of A-B oligomers (V-VIII). The A-A-D (IV) formation, which cannot be
cleaved by DTT, was analyzed more precisely by MALDI mass spectrometry
(Fig. 5). Ten peptides were unequivocally
identified as bands deriving from either the N or C terminus of subunit
D, together with five peptides of subunit A (see Table
II). However, we were not able to monitor unequivocally the specific peptide of each subunit forming the linkage.
This might be due to the incompleteness of in-gel tryptic digestion of
the polypeptides (37), which covers only 47.8 and 23.9% of the D and A
sequence, respectively. The presence of MgADP leads to a slight
decrease of the A-A-D (IV) formation and additionally to several
closely spaced bands running just above band VIII, including A-B and
A-A formations as shown by antibody blotting (Fig. 4B).
Consistently, the staining intensity of the A and B bands decreased in
parallel with the occurrence of these A-B and A-A oligomer bands. These
results rule out that MgATP was completely converted into MgADP or
MgADP + Pi before cross-link formation under the conditions
used, and it can be concluded that the differences in the fluorescence
spectra seen above depend on whether MgATP or MgADP is bound in the
nucleotide-binding site of the A1-ATPase. As shown by MALDI
mass spectrometry, addition of MgADP leads to an intrinsic cross-link
of the contaminant DnaK (band II). A cross-linked B product (I) and an
A-B oligomer formation (V) were also formed in the presence of the
A1 inhibitor dienestrol (17) and under atmospheric oxygen
without CuCl2 as shown by two-dimensional SDS-PAGE (Fig.
4C). Addition of DTT after CuCl2 treatment
reversed cross-linking of the oxidized A1 complex.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 4.
Characterization of cross-linking products in
A1-ATPase due to nucleotide binding. A, the
enzyme was supplemented with 5 mM MgAMP-PNP, MgATP, MgADP,
and MgADP + Pi or with the A1-ATPase inhibitor
dienestrol (0.4 µM) for an incubation time of 5 min at
4 °C, followed by addition and incubation of 2 mM
CuCl2 for 30 min at 4 °C. The reaction was stopped by
addition of 10 mM EDTA. The control containing no
nucleotides is shown in lanes 6 and 8. 8 µg of
enzyme were applied per lane after addition of DTT-free dissociation
buffer or after addition of 1 mM DTT (lane 8).
Cross-link products are marked by I-VIII. The gel was
stained with Coomassie Blue G-250. B,
immunoblot of the same samples with polyclonal rabbit antisera
di- rected against the A and B subunits of the
A1 complex. C, two-dimensional SDS-PAGE to
analyze the cross-link products I and V. Lane 6 of the gel
in A were cut out, destained, soaked in buffer consisting of
20 mM Tris-HCl (pH 6.9) and 150 mM NaCl, 50 mM DTT, and 0.5% SDS, and placed onto a 17.5% total
acrylamide and 0.4% cross-linked acrylamide gel.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
Detail of a MALDI-TOF mass spectrum of
peptides from subunit D involved in the cross-link product
IV.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
MALDI-mass spectrometry analysis of peptides from subunits A and D
involved in the cross-linking product IV
|
|
Nucleotide-dependent Trypsin Treatment of the
A1-ATPase--
Recently, limited tryptic digestion of
A1 has shown that the subunits A-C are cleaved most
rapidly, leading to the fragments A1-4, B1,
C1, followed by F, which becomes cleaved into fragment
F1, whereby subunit D remains shielded by the complex (14).
The cleavage products and their intensities were the same as observed
upon trypsin treatment of A1 in the presence of 5 mM MgAMP-PNP (Fig.
6A), with subunit F cleaved
into fragment F1 after 20 min (data not shown). In
contrast, there is slow cleavage of these subunits with MgATP or MgADP.
Subunit C, which completely vanishes in the absence (14) or presence of
MgAMP-PNP after 50 min, is slowly cleaved when MgATP or MgADP is added
to the enzyme. There is, however, a slight difference in cleavage of this stalk subunit depending on whether MgATP or MgADP is bound. Quantitation of the scanned C-bands indicate that 43 and 59.4% of this
subunit remained after 70 min when MgATP or MgADP, respectively, is
bound to the enzyme (Fig. 6B). Proteolysis of A1
after addition of MgADP + Pi leads to a
time-dependent cleavage pattern in which only 4.7% of
subunit C remained after 70 min. Furthermore, under this nucleotide
condition the subunits A, B, and F also become more accessible to
trypsin than in the presence of MgATP or MgADP. Interestingly, the
cleavage pattern of the MgADP + Pi-bound
A1-complex is quite comparable with the feature seen when
MgAMP-PNP is present. This is in agreement with the results of
Cu2+-induced cross-link formations described above when
MgADP + Pi or MgAMP-PNP are bound to the enzyme.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 6.
Electrophoretic analysis and quantitation
of nucleotide-dependent trypsin cleavage of
A1-ATPase. A, the A1-complex
was incubated for 5 min with 5 mM MgAMP-PNP, MgATP, MgADP,
or MgADP + Pi before trypsin cleavage (ratio of 900:1
(w/w)) for the indicated times. Proteolysis was stopped by addition of
the protease inhibitor Pefabloc SC to a final concentration of 8 mM. Samples were electrophoresed on a 17.5% total
acrylamide and 0.4% cross-linked acrylamide gel and stained with
Coomassie Blue G-250. B, quantitation of the
nucleotide-dependent cleavage of subunit C. Relative
intensities of the protein bands of subunit C at each time point and
under the nucleotide conditions described above were determined by
scanning the gel of A with an HP (ScanJet 4c) flat-bed
scanner. The intensity of each protein band was digitized and
calculated by the program AIDA 2.40 (advanced image analyzer; RAYTEST).
The symbols labeling the different nucleotide conditions used are shown
in the inset.
|
|
 |
DISCUSSION |
X-ray solution scattering was used to investigate the influence of
nucleotide binding to the quaternary structure of the
A1-ATPase from M. mazei Gö1. Binding of
the uncleaved MgATP (obtained by adding MgAMP-PNP) causes a slight
decrease of the radius of gyration of this complex, consistent with the
observation on the closely related F1FO-ATPase
from E. coli, where the diameter of the F1 complex decreases upon MgAMP-PNP binding as determined by
three-dimensional reconstructions (38). In contrast, addition of the
hydrolyzable MgATP, MgADP + Pi, and MgADP increase the
radii of gyration. Conformational changes of the quaternary and
tertiary structure of the related F1 due to nucleotide
binding are in line with the most recent crystallographic model of
bovine F1-ATPase, indicating changes of the quaternary and
tertiary structure of the complex (39). Depending on the nucleotide
bound to one of the catalytic
subunits significant changes of the
lower part of the nucleotide binding domain and the C-terminal domain
have been observed. Superposition of the so-called
DP,
TP, and
ADP+Pi
subunits of the bovine F1-ATPase (39) indicate a 33°
rotation of the C-terminal domain of
ADP+Pi when
compared with
DP and significant changes in backbone
torsion angles in regions of the nucleotide binding domain.
Incorporation of the fluorescent label CM into the nucleotide-binding site A and B of A1, as described above, provides strong
evidence for rearrangements of these subunits, which also suggests that the small but systematic differences observed in SAXS are significant. Addition of MgADP causes a significant fluorescent enhancement and blue
shift, whereas the binding of MgAMP-PNP only increases the signal. In
contrast, the presence of MgADP + Pi results in a quenching
of the signal, suggesting that structural changes in and around the
bound CM occur in response to ATP binding and subsequent bond cleavage
to ADP and Pi.
The nucleotide-induced rearrangement of the major subunits A and B is
also confirmed by the quantity of Cu2+-induced A-B dimers
or the formation of A-B oligomers. The formation of A-B oligomers
reflects the proximity of these subunits, which are proposed to
alternate around a cavity in a hexameric fashion, thereby locating the
nucleotide-binding sites at their interfaces (2, 40). Significantly,
A-A dimers can be observed even though separated by an intervening B
subunit. Close proximity of the related
and
subunits of the
F1-ATPase has also been demonstrated by
-
or
-
products formed via disulfide bridges of the N or C terminus,
respectively (35, 41). Like in the closely related V-ATPases, the
A1 subunit A contains a region of 80-90 additional amino
acids near the N terminus (5, 6, 33). This extension is assumed to be
located at the top of the three A subunits, forming protuberances as
described for the V-ATPase (10, 13, 42). Therefore, depending on
nucleotide binding to the catalytic A subunits, these protuberances
might come in close contact thereby facilitating an A-A formation.
A key finding of the present study is that subunit D can be
cross-linked to the catalytic A subunit depending on nucleotide binding. The A-D formation occurs after addition of MgADP and to a
small amount in the presence of the hydrolyzable MgATP but not in the
presence of MgADP + Pi, MgAMP-PNP, or the absence of nucleotides. The interaction between the subunits A and D involves the
N and C termini of D, indicating their close proximity to the catalytic
A subunit. It is of particular interest that neither of the termini of
D contain Cys residues and that the cross-linked formation cannot be
disrupted by reducing agents, which rules out that the A-D product
would be generated by disulfide bond formation. Inspection of the amino
acid sequence of the peptides from subunit D reveals the presence of a
His27 and a Tyr184 residue at the N and C
termini of this subunit, respectively, both candidates to form a
thioether bridge with a cysteinyl residue. Such covalent linkage
of the sulfur of a Cys with an imidazole ring of a His residue or with
a Tyr residue has been identified as an essential formation in the
tyrosinase from Neurospora crassa (43) and the galactose
oxidase from Dactylium dendroides (44), respectively, and
also occurred in cross-linking studies of the ATP synthase from
E. coli (45). This close proximity of subunits A and D would
allow coupling between the catalytic site events in A via D into the
central stalk, which provides the physical and structural linkage
between the A3B3 headpiece and the
ion-conducting complex (2, 3). Secondary structure analysis of D
predicted
-helical N and C termini (33, 45), as shown for both
termini of subunit
of F-ATPase (12, 47, 48), which has been
proposed as a structural and functional homologue of subunit D (3, 14, 33, 46). The x-ray structure revealed that the
-helical N and C
termini of
intercalate into the cavity of the
3
3 assembly of F1 (12, 48,
49), thereby linking two differently occupied catalytic subunits,
TP (triphosphate-containing) and
DP
(diphosphate-containing) (39).
Taken together, the results above provide several lines of evidence
suggesting that, depending on the nucleotides bound to them, subunits A
and B of the A1-ATPase change conformation and/or their
interactions with structural alterations in the stalk subunits C, D,
and F. The nucleotide dependence suggests also that there is a tight
interaction of the D subunit at its catch region with the A subunit
upon MgADP binding, which is broken when MgAMP-PNP is bound. Such
binding followed by release may play a part in coupling the catalytic
sites with the stalk region and the membrane-bound ion channel.
 |
ACKNOWLEDGEMENT |
We thank R. Genswein, Universität
Mainz, for excellent technical assistance.
 |
FOOTNOTES |
*
This work was supported by Deutsche Forschungsgemeinschaft
Grant Mu801/10-1 (to V. M.) and Grant GR 1475/9-1 (to G. G.), the International Association for the Promotion of Cooperation with Scientists from the Independent States of the Former Soviet Union (INTAS Contract 01-243 (to M. H. J. K.), and the Special Trustees of
the Middlesex and University College Hospital G.83.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Universität des
Saarlandes, Fachrichtung 2.5 Biophysik, Universitätsbau 76, D-66421 Homburg, Germany. Tel.: 49-6841-162-6085; Fax:
49-6841-162-6160; E-mail: ggrueber@med-rz.uni-saarland.de.
Published, JBC Papers in Press, February 19, 2002, DOI 10.1074/jbc.M110407200
1
T. Lemker and V. Müller, manuscript in preparation.
3
D. I. Svergun and M. H. J. Koch,
unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
FPLC, fast protein
liquid chromatography;
CM, N-[4-[7-(dimethylamino)-4-methyl]coumarin-3-yl)]maleimide;
AMP-PNP, adenosine 5'-(
,
-imino)triphosphate;
MALDI-TOF, matrix-assisted laser desorption ionization time-of-flight;
DTT, dithiothreitol;
SAXS, by small-angle x-ray scattering.
 |
REFERENCES |
| 1.
|
Perzov, N.,
Padler-Karavani, V.,
Nelson, H.,
and Nelson, N.
(2001)
FEBS Lett.
504,
223-228[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Schäfer, G.,
Engelhard, M.,
and Müller, V.
(1999)
Mol. Biol. Rev.
63,
570-620[Abstract/Free Full Text]
|
| 3.
|
Grüber, G.,
Wieczorek, H.,
Harvey, W. R.,
and Müller, V.
(2001)
J. Exp. Biol.
204,
2597-2605[Abstract/Free Full Text]
|
| 4.
|
Gogarten, J. P.
(1995)
Trends Ecol. Evol.
10,
147-151[CrossRef]
|
| 5.
|
Hilario, E.,
and Gogarten, J. P.
(1998)
J. Mol. Evol.
46,
703-715[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Marin, I.,
Fares, M. A.,
Gonzáles-Candelas, F.,
Barrio, E.,
and Moya, A.
(2001)
J. Mol. Evol.
52,
17-28[Medline]
[Order article via Infotrieve]
|
| 7.
|
Lübben, M.,
Lünsdorf, H.,
and Schäfer, G.
(1988)
Biol. Chem. Hoppe-Seyler
369,
1259-1266[Medline]
[Order article via Infotrieve]
|
| 8.
|
Radermacher, M.,
Ruiz, T.,
Harvey, W. R.,
Wieczorek, H.,
and Grüber, G.
(1999)
FEBS Lett.
453,
383-386[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Gogol, E. P.,
Lücken, U.,
Bork, T.,
and Capaldi, R. A.
(1989)
Biochemistry
28,
4709-4716[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Grüber, G.,
Radermacher, M.,
Ruiz, T.,
Godovac-Zimmermann, J.,
Canas, B.,
Kleine-Kohlbrecher, D.,
Huss, M.,
Harvey, W. R.,
and Wieczorek, H.
(2000)
Biochemistry
39,
8609-8616[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Gogol, E. P.,
Aggeler, R.,
Sagermann, M.,
and Capaldi, R. A.
(1989)
Biochemistry
28,
4717-4724[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Gibbons, C.,
Montgomery, M. G.,
Leslie, A. G. W.,
and Walker, J. E.
(2000)
Nat. Struct. Biol.
7,
1055-1061[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Radermacher, M.,
Ruiz, T.,
Wieczorek, H.,
and Grüber, G.
(2001)
J. Struct. Biol.
135,
26-37[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Grüber, G.,
Svergun, D. I.,
Coskun, Ü.,
Lemker, T.,
Koch, M. H. J.,
Schägger, H.,
and Müller, V.
(2000)
Biochemistry
40,
1890-1896
|
| 15.
|
Grüber, G.
(2000)
J. Bioenerg. Biomembr.
32,
341-346[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Yoshida, M.,
Muneyuki, E.,
and Hisabori, T.
(2001)
Nat. Rev. Mol. Cell. Biol.
2,
669-677[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Lemker, T.,
Ruppert, C.,
Stöger, H.,
Wimmers, S.,
and Müller, V.
(2001)
Eur. J. Biochem.
268,
3744-3750[Medline]
[Order article via Infotrieve]
|
| 18.
|
Schägger, H.,
and von Jagow, G.
(1991)
Anal. Biochem.
199,
223-231[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Lowry, O. H.,
Rosebrough, N. J.,
Farr, A. L.,
and Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-275[Free Full Text]
|
| 21.
|
Heinonen, J. K.,
and Lahti, R. J.
(1981)
Anal. Biochem.
113,
313-317[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Towbin, H.,
Staehelin, T.,
and Gordon, J.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4350-4354[Abstract/Free Full Text]
|
| 23.
|
Hellman, U.,
Wernstedt, C.,
Gonez, J.,
and Heldin, C.-H.
(1995)
Anal. Biochem.
224,
451-455[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Roos, M.,
Soskic, V.,
Poznanovic, S.,
and Godovac-Zimmermann, J.
(1998)
J. Biol. Chem.
273,
924-931[Abstract/Free Full Text]
|
| 25.
|
Bullough, D. A.,
Brown, E. L.,
Saario, J. D.,
and Allison, W. S.
(1988)
J. Biol. Chem.
263,
14053-14060[Abstract/Free Full Text]
|
| 26.
|
Grüber, G.,
Hausrath, A.,
Sagermann, M.,
and Capaldi, R. A.
(1997)
FEBS Lett.
410,
165-168[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Koch, M. H. J.,
and Bordas, J.
(1983)
Nucl. Instrum. Methods
208,
461-469[CrossRef]
|
| 28.
|
Boulin, C.,
Kempf, R.,
Koch, M. H. J.,
and McLaughlin, S. M.
(1986)
Nucl. Instrum. Methods
249,
399-407[CrossRef]
|
| 29.
|
Boulin, C. J.,
Kempf, R.,
Gabriel, A.,
and Koch, M. H. J.
(1988)
Nucl. Instrum. Methods
269,
312-320[CrossRef]
|
| 30.
|
Gabriel, A.,
and Dauvergne, F.
(1982)
Nucl. Instrum. Methods
201,
223-224[CrossRef]
|
| 31.
|
Svergun, D. I.
(1993)
J. Appl. Crystallogr.
26,
258-267[CrossRef]
|
| 32.
|
Svergun, D. I.,
Semenyuk, A. V.,
and Feigin, L. A.
(1988)
Acta Crystallogr. Sect. A
44,
244-250[CrossRef]
|
| 33.
|
Wilms, R.,
Freiberg, C.,
Wegerle, E.,
Meier, I.,
Mayer, F.,
and Müller, V.
(1996)
J. Biol. Chem.
271,
18843-18852[Abstract/Free Full Text]
|
| 34.
|
Aggeler, R.,
Haughton, M. A.,
and Capaldi, R. A.
(1995)
J. Biol. Chem.
270,
9185-9191[Abstract/Free Full Text]
|
| 35.
|
Tsunoda, S. P.,
Muneyuki, E.,
Amano, T.,
Yoshida, M.,
and Noji, H.
(1999)
J. Biol. Chem.
274,
5701-5706[Abstract/Free Full Text]
|
| 36.
|
Hutcheon, M. L.,
Duncan, T. M.,
Ngai, H.,
and Cross, R. L.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
8519-8524[Abstract/Free Full Text]
|
| 37.
|
Svoboda, M.,
Meister, W.,
and Vetter, W.
(1995)
J. Mass. Spectrom.
30,
1562-1566[CrossRef]
|
| 38.
|
Böttcher, B.,
Bertsche, I.,
Reuter, R.,
and Gräber, P.
(2000)
J. Mol. Biol.
296,
449-457[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Menz, R. I.,
Walker, J. E.,
and Leslie, A. G.
(2001)
Cell
106,
331-341[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Schäfer, G.,
and Meyering-Vos, M.
(1992)
Biochim. Biophys. Acta
1101,
232-235[Medline]
[Order article via Infotrieve]
|
| 41.
|
Ogilvie, I.,
Aggeler, R.,
and Capaldi, R. A.
(1997)
J. Biol. Chem.
272,
16652-16656[Abstract/Free Full Text]
|
| 42.
|
Wilkens, S.,
Vasilyeva, E.,
and Forgac, M.
(1999)
J. Biol. Chem.
274,
31804-31810[Abstract/Free Full Text]
|
| 43.
|
Lerch, K.
(1982)
J. Biol. Chem.
257,
6414-6419[Abstract/Free Full Text]
|
| 44.
|
Ito, N.,
Phillips, S. E. V.,
Stevens, C.,
Ogel, Z. B.,
McPherson, M. J.,
Keen, J. N.,
Yadav, K. D. S.,
and Kowles, P. F.
(1991)
Nature
350,
87-90[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Watts, S. D.,
Zhang, Y.,
Fillingame, R. H.,
and Capaldi, R. A.
(1995)
FEBS Lett.
368,
235-238[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Müller, V.,
Ruppert, C.,
and Lemker, T.
(1999)
J. Bioenerg. Biomembr.
31,
15-27[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Rodgers, A. J. W.,
and Wilce, M. C. J.
(2000)
Nat. Struct. Biol.
7,
1051-1054[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Hausrath, A. C.,
Grüber, G.,
Matthews, B. W.,
and Capaldi, R. A.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
13697-13702[Abstract/Free Full Text]
|
| 49.
|
Hausrath, A. C.,
Capaldi, R. A.,
and Matthews, B. W.
(2001)
J. Biol. Chem.
276,
47227-47232[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
U. Coskun, Y. L. Chaban, A. Lingl, V. Muller, W. Keegstra, E. J. Boekema, and G. Gruber
Structure and Subunit Arrangement of the A-type ATP Synthase Complex from the Archaeon Methanococcus jannaschii Visualized by Electron Microscopy
J. Biol. Chem.,
September 10, 2004;
279(37):
38644 - 38648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Coskun, M. Radermacher, V. Muller, T. Ruiz, and G. Gruber
Three-dimensional Organization of the Archaeal A1-ATPase from Methanosarcina mazei Go1
J. Biol. Chem.,
May 21, 2004;
279(21):
22759 - 22764.
[Abstract]
[Full Text]
[PDF]
|
 |
|